ATXN2 and amyotrophic lateral sclerosis: Our interpretation is that ATXN2 CAG-repeat expansions, irrespective of length, should be considered a risk factor for both familial and sporadic ALS in a similar manner to G4C2-repeat expansion within C9ORF72 [10] although not with the same effect-size.